The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of compliance on outcomes for patients on active surveillance for prostate cancer.
 
Jay Detsky
No Relationships to Disclose
 
Alireza Fotouhi Ghiam
No Relationships to Disclose
 
Alexandre Mamedov
No Relationships to Disclose
 
Kristina Commisso
No Relationships to Disclose
 
Angela Commisso
No Relationships to Disclose
 
Laurence Klotz
Stock and Other Ownership Interests - Medivation
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Profound Medical; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; Ferring; Profound Medical; Tolmar
Research Funding - Abbvie; Bayer; Ferring; Medivation/Astellas
Expert Testimony - Astellas Pharma
 
Stanley K. Liu
No Relationships to Disclose
 
Andrew Loblaw
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb (I); Ferring; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I)
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb (I); Ferring; GlaxoSmithKline (I); Janssen Oncology; Merck (I); Novartis (I); Roche (I)
Patents, Royalties, Other Intellectual Property - Prostate immobilization device (GU-Lok)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen Oncology
 
Danny Vesprini
No Relationships to Disclose